Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 11Unknown 7Recruiting 3Terminated 2Withdrawn 1Suspended 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms, Plasma Cell 3Multiple Myeloma 3Leukemia 2Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

Homoharringtonine 1Gemtuzumab 1Drug Therapy 1Arsenic Trioxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Leukemia, Promyelocytic, Acute × Arsenic Trioxide × Clear all
NCT00670150 2015-10-27

New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia

University of Southern California

Phase 2 Withdrawn
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡